Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Network
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
Latest news
Launch of the EXIMIOUS Symposium series
Register now and join us online at 16:00 – 18:00 (CET) for the first EXIMIOUS Symposium “Exposome-immunome interactions: A broad introduction”.
Partner in the spotlight: Imec
Headquartered in Leuven, Belgium, Imec is a world-leading research and innovation hub in nanoelectronics and digital technologies and is a leader in combining microchip technology, software, and ICT. Imec’s research bridges the gap between fundamental research at universities and technology development in industry.
Latest Tweets
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.